Science company, Thermo Fisher Scientific has reported strong second quarter growth in 2010. This is due to the success of its investment and new product initiatives.
Thermo Fisher Scientific’s laboratory products and analytical technologies have benefit from the growth, whilst its molecular and cellular biology activities have been boosted by the acquisition of Fermentas.
The science company are looking to support their future expansion with new innovations in life sciences, clinical research and specialist diagnostics.
Marc Casper, president and chief executive officer of Thermo Fisher Scientific, said: “We successfully leveraged our top-line performance to achieve solid operating margin expansion and double-digit EPS growth.”
Are you looking for a new position in the scientific industry? Click here to search our current science jobs online now.